Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients

Abstract Immunotherapy has transformed the treatment landscape for non-small cell lung cancer (NSCLC), yet achieving lasting benefits remains a challenge. The resistance mechanisms to immunotherapy are complex, involving interactions between tumor cells and immune cells that are not fully understood...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Luisa Amato, Caterina De Rosa, Gaetano Di Guida, Filippo Sepe, Annalisa Ariano, Sara Capaldo, Faiz Ul Haq, Alessandra Di Liello, Concetta Tuccillo, Stefano Lucà, Renato Franco, Viviana De Rosa, Francesca Iommelli, Alberto Servetto, Fortunato Ciardiello, Carminia Maria Della Corte, Floriana Morgillo
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Nature Publishing Group 2025-04-01
Σειρά:	Cell Death and Disease
Διαθέσιμο Online:	https://doi.org/10.1038/s41419-025-07636-7
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!